A61K 31/433
Thidiazoles
A61K31/433 (Thidiazoles) appears on 674 US grants and 1,311 published applications in this corpus.
Search patents in A61K- Granted patents
- 674
- Published applications
- 1,311
- Assignees
- 635
- Inventors
- 3,134
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 6 | 0 |
| 1999 | 6 | 0 |
| 2000 | 4 | 0 |
| 2001 | 6 | 2 |
| 2002 | 11 | 13 |
| 2003 | 4 | 27 |
| 2004 | 4 | 38 |
| 2005 | 10 | 42 |
| 2006 | 11 | 31 |
| 2007 | 8 | 34 |
| 2008 | 9 | 35 |
| 2009 | 8 | 27 |
| 2010 | 13 | 43 |
| 2011 | 12 | 43 |
| 2012 | 22 | 36 |
| 2013 | 33 | 52 |
| 2014 | 31 | 75 |
| 2015 | 48 | 71 |
| 2016 | 37 | 77 |
| 2017 | 59 | 80 |
| 2018 | 52 | 80 |
| 2019 | 61 | 74 |
| 2020 | 47 | 60 |
| 2021 | 36 | 49 |
| 2022 | 25 | 63 |
| 2023 | 21 | 64 |
| 2024 | 38 | 62 |
| 2025 | 26 | 70 |
| 2026 | 24 | 63 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for treating fungal infections6 Oct 2026US 12,751,944 B2Neoculi Pty Ltd
- Solid state forms of Tideglusib and process for preparation thereof22 Sep 2026US 12,740,969 B2Assia Chemical Industries Ltd.
- Bacterial DNA gyrase inhibitors and methods of use thereof25 Aug 2026US 12,714,692 B2The Florida International University Board of Trustees
- Compounds for inhibition of inflammation25 Aug 2026US 12,714,716 B2Children's Medical Center Corporation
- Compositions and methods for treating granulomatosis with polyangiitis11 Aug 2026US 12,702,701 B2Canem Holdings, LLC
- Biarylamide derivatives and their use as pkmyt1 inhibitors1 Oct 2026US 2026/0297042 A1Cancer Research Technology Limited
- Bicyclic compounds as cdk inhibitors1 Oct 2026US 2026/0297080 A1BeOne Medicines I GmbH
- Inhibitors of parg24 Sep 2026US 2026/0285875 A1858 Therapeutics, Inc.
- Err modulators17 Sep 2026US 2026/0274807 A1University of Health Sciences & Pharmacy in St. Louis
- Cgas antagonist compounds17 Sep 2026US 2026/0274808 A1Board of Regents, The University of Texas System
Most cited
By later US patents
- Composition for treating pain79US 5,998,434 AEli Lilly and Company · 1999
- Npyy5 antagonists74US 6,699,891 B1Shionogi & Co., Ltd. · 2004
- Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4.71US 7,049,306 B2Elan Pharmaceuticals, Inc. · 2006
- Buccal, polar and non-polar spray or capsule68US 6,676,931 B2NovaDel Pharma, Inc. · 2004
- Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system50US 6,977,070 B2NovaDel Pharma, Inc. · 2005